ArticleBMC public health2024
Assessment of national reimbursement anticancer medications availability in China: based on a medical institution perspective.
Wenxin Meng et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it